Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk.
Rebbeck
Timothy R
TR
Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6021, USA. trebbeck@cceb.med.upenn.edu
Troxel
Andrea B
AB
Shatalova
Ekaterina G
EG
Blanchard
Rebecca
R
Norman
Sandra
S
Bunin
Greta
G
Demichele
Angela
A
Schinnar
Rita
R
Berlin
Jesse A
JA
Strom
Brian L
BL
D000368:Aged; D015239:Arylsulfotransferase / Q000235:genetics; D001943:Breast Neoplasms / Q000139:chemically induced* / Q000235:genetics*; D002394:Catechol O-Methyltransferase / Q000235:genetics; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004967:Estrogens / Q000009:adverse effects / Q000235:genetics* / Q000378:metabolism*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011372:Progestins / Q000009:adverse effects / Q000378:metabolism
D004967:Estrogens; D011372:Progestins; D003577:Cytochrome P-450 Enzyme System; D002394:Catechol O-Methyltransferase; D015239:Arylsulfotransferase; C117544:SULT1A1 protein, human